Talkspace TALK Q1 2026 Earnings Significant EPS Miss as Losses Widen Stock Unchanged Legal Turbulence Erupts States Challenge Prediction Markets as Regulators Weigh In Compass Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Takes Center Stage Compass Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Takes Center Stage TEAM Q1 2026 Earnings Strong EPS Beat Fails to Lift Stock as Market Weighs Growth Concerns American Rebel Holdings Inc AREB Q1 2026 Earnings Steep Loss and Market Downturn Signal Challenging Quarter